Bioventix's (LON:BVXP) Dividend Will Be £0.68
Mar 29
U.K. (FTSE) Biotech Industry Analysis
UpdatedMay 09, 2024
DataAggregated Company Financials
Companies26
- 7D4.0%
- 3M-7.3%
- 1Y-23.5%
- YTD-9.3%
In the last week, the Biotech industry is up 4.0%, with Genus up 5.4%. In the past year, the industry is down 24%. As for the next few years, earnings are expected to grow by 27% per annum.
Industry Valuation and Performance
Has the U.K. Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 09 May 2024 | UK£3.0b | UK£836.4m | -UK£300,084,358.56 | 31.4x | -10x | 3.6x |
| Sat, 06 Apr 2024 | UK£3.0b | UK£902.4m | -UK£200,893,434.97 | 28.7x | -15.2x | 3.4x |
| Mon, 04 Mar 2024 | UK£3.0b | UK£897.8m | -UK£203,905,345.05 | 33x | -14.9x | 3.4x |
| Wed, 31 Jan 2024 | UK£6.4b | UK£1.3b | -UK£245,323,461.00 | 37.8x | -26.2x | 5.1x |
| Fri, 29 Dec 2023 | UK£6.4b | UK£1.3b | -UK£245,096,788.00 | 38.2x | -25.9x | 5x |
| Sun, 26 Nov 2023 | UK£6.3b | UK£1.3b | -UK£245,852,859.00 | 37.1x | -25.5x | 4.9x |
| Tue, 24 Oct 2023 | UK£6.5b | UK£1.3b | -UK£250,836,330.00 | 39.2x | -25.8x | 5.1x |
| Thu, 21 Sep 2023 | UK£6.7b | UK£1.3b | -UK£229,236,837.00 | 23.6x | -29.1x | 5.3x |
| Sat, 19 Aug 2023 | UK£6.6b | UK£1.3b | -UK£207,866,392.00 | 23.6x | -31.8x | 5.3x |
| Mon, 17 Jul 2023 | UK£6.8b | UK£1.3b | -UK£207,414,117.00 | 23.7x | -32.8x | 5.4x |
| Wed, 14 Jun 2023 | UK£7.0b | UK£1.3b | -UK£205,840,859.00 | 23x | -33.9x | 5.5x |
| Fri, 12 May 2023 | UK£9.2b | UK£1.3b | -UK£205,460,971.00 | 24x | -44.6x | 7.3x |
| Sun, 09 Apr 2023 | UK£7.2b | UK£1.2b | -UK£154,069,522.00 | 24.2x | -46.6x | 5.8x |
| Tue, 07 Mar 2023 | UK£7.6b | UK£1.2b | -UK£156,716,379.00 | 27.1x | -48.2x | 6.1x |
| Thu, 02 Feb 2023 | UK£7.4b | UK£1.2b | -UK£146,728,541.00 | 26.3x | -50.5x | 6.4x |
| Sat, 31 Dec 2022 | UK£7.5b | UK£1.2b | -UK£138,775,088.00 | 27.1x | -53.9x | 6.4x |
| Mon, 28 Nov 2022 | UK£7.7b | UK£1.2b | -UK£139,203,033.00 | 24.4x | -55.6x | 6.7x |
| Wed, 26 Oct 2022 | UK£7.1b | UK£1.2b | -UK£148,866,026.00 | 22.7x | -47.5x | 6.1x |
| Fri, 23 Sep 2022 | UK£7.4b | UK£1.2b | -UK£173,424,767.00 | 26.4x | -42.4x | 6.3x |
| Sun, 21 Aug 2022 | UK£7.6b | UK£1.1b | -UK£203,428,822.00 | 37.1x | -37.2x | 6.8x |
| Tue, 19 Jul 2022 | UK£6.8b | UK£1.1b | -UK£202,968,472.00 | 34.1x | -33.4x | 6.1x |
| Thu, 16 Jun 2022 | UK£6.7b | UK£1.1b | -UK£159,948,219.00 | 36.2x | -41.7x | 6x |
| Sat, 14 May 2022 | UK£6.9b | UK£1.1b | -UK£146,427,737.00 | 36.6x | -47.1x | 6.2x |
| Mon, 11 Apr 2022 | UK£7.6b | UK£1.1b | -UK£91,993,248.00 | 41.6x | -82.7x | 7x |
| Wed, 09 Mar 2022 | UK£7.3b | UK£1.1b | -UK£132,459,108.00 | 30.7x | -54.7x | 6.7x |
| Fri, 04 Feb 2022 | UK£8.9b | UK£1.1b | -UK£119,845,425.00 | 37.7x | -74.3x | 8.2x |
| Sun, 02 Jan 2022 | UK£11.5b | UK£1.1b | -UK£120,779,727.00 | 57.3x | -94.9x | 10.6x |
| Tue, 30 Nov 2021 | UK£11.2b | UK£1.1b | -UK£123,020,844.00 | 63.1x | -91.3x | 10.3x |
| Thu, 28 Oct 2021 | UK£12.4b | UK£1.1b | -UK£148,848,064.00 | 69.5x | -83.4x | 11.3x |
| Sat, 25 Sep 2021 | UK£12.3b | UK£1.1b | -UK£118,788,788.00 | 69.7x | -103.2x | 11.1x |
| Mon, 23 Aug 2021 | UK£12.4b | UK£1.0b | -UK£172,541,949.91 | 31.1x | -71.6x | 12.1x |
| Sat, 10 Jul 2021 | UK£11.2b | UK£1.0b | -UK£172,541,949.91 | 30.1x | -65x | 11x |
Price to Earnings Ratio
-68.3x
Current Industry PE
- Investors are pessimistic on the British Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 7.4x is higher than the industry's current PS ratio of 3.6x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Revenues have also declined 6.3% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the U.K. Healthcare industry?
| GB Market | 2.66% | |
| Healthcare | 1.91% | |
| Biotech | 4.00% | |
| Biotech | 4.00% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GNS Genus | UK£18.80 | 5.4% +UK£62.9m | -27.8% | PE36.9x | |
| OXB Oxford Biomedica | UK£3.35 | 16.7% +UK£48.0m | -16.7% | PS3.7x | |
| PRTC PureTech Health | UK£2.22 | 3.5% +UK£20.3m | 2.1% | PS224.8x | |
| SCLP Scancell Holdings | UK£0.099 | 6.8% +UK£5.1m | -35.2% | PE-8.5x | |
| FARN Faron Pharmaceuticals Oy | UK£1.55 | 3.3% +UK£3.6m | -49.2% | PE-4.2x |